Santarus licenses approved diabetes drug for $5M - BusinessWeek
Santarus licenses approved diabetes drug for $5MBusinessWeekSantarus Inc. said Wednesday it bought the rights to make and sell a new type 2 diabetes drug from two other drugmakers, and its shares surged in Thursday ...and more��
Blog Content
No comments:
Post a Comment